High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
- Resource Type
- Article
- Source
- Discover Oncology; 12/13/2023, p1-11, 11p
- Subject
NON-small-cell lung carcinoma RECEIVER operating characteristic curves TREATMENT effectiveness GINGER UNIVARIATE analysis INDEPENDENT variables - Language
- ISSN
- 27306011